FKRP-related muscular dystrophy-dystroglycanopathy is part of a family of muscle conditions caused by changes to a particular protein called alpha-dystroglycan. Symptoms of FKRP-related muscular dystrophy-dystroglycanopathy include progressive muscle weakness, particularly in the limbs and sometimes the heart and lungs; and changes in the brain that can delay development and cause intellectual disability and seizures.
In the most severe form, known as Walker-Warburg syndrome, sadly children generally do not survive past early childhood. Other FKRP-related muscular dystrophy-dystroglycanopathies are milder and more variable. Some people live to adulthood with significant muscle weakness, while others learn to walk but may experience muscle weakness or intellectual disability. Treatment aims to support individual symptoms.
|Alternative Names:||muscular dystrophy-dystroglycanopathy A5, muscular dystrophy-dystroglycanopathy B5, muscular dystrophy-dystroglycanopathy C5, Limb-girdle muscular dystrophy, Walker-Warburg syndrome|
As humans we have about 23,000 genes. These genes are like tiny instruction manuals that influence our health, growth and development. We inherit half of our genes from our biological mum and the other half from our biological dad. These genes are lined up on structures called chromosomes. Most of us have 23 pairs of chromosomes. The first 22 pairs are called autosomes and for the most part - these are the same among men and women. The 23rd pair determine our sex - two X chromosomes for a female and one X and one Y chromosome for males.
Muscular dystrophy-dystroglycanopathy (FKRP-related) is known as an autosomal recessive condition. For autosomal recessive conditions, if a person has a variation in one copy of their gene, they are a carrier. This means that they are healthy because they also have a working copy of the gene. But, they can still pass their non-working copy to their child.
If the other parent also happens to be a carrier of the same gene, there is a 25% (1 in 4) chance that they both pass this gene variation on to their child — and as such, have a child affected by the condition.
If both parents are carriers of Muscular dystrophy-dystroglycanopathy (FKRP-related), there's a one in four chance that their children could develop symptoms.
Carrier testing is like a checkup for your genes. It tests to see if you carry a gene variation that could cause a serious genetic condition in your child. Eugene offers an inclusive genetic carrier screening panel that includes Muscular dystrophy-dystroglycanopathy (FKRP-related), but there's a total 301 conditions that can be tested.
Eugene's carrier test is a clinical grade test that can be done from the comfort of your own home — it's just a saliva test. You're also paired with a genetic counsellor who provides mindful support and guidance every step of the way.Learn more about carrier screening
The biggest benefit of screening for Muscular dystrophy-dystroglycanopathy (FKRP-related) is that it can help future parents understand their reproductive risk so they can be ready and empowered to make more informed decisions. If neither partner are carriers, it provides reassurance and peace of mind that the risk of having a child with a genetic condition is low.
Since 90% of children that have a recessive genetic condition like Muscular dystrophy-dystroglycanopathy (FKRP-related) had no previous family history of it, it often feels completely out of the blue for the parents. Getting screened is a way to know this risk in advance, which can help familes manage or even prevent the condition in the first place.